Skip to Content

Getinge AB Class B GNGBF

Morningstar Rating
$19.56 −0.69 (3.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GNGBF is trading at a 18% discount.
Price
$19.57
Fair Value
$49.64
Uncertainty
High
1-Star Price
$29.29
5-Star Price
$14.79
Economic Moat
Mvjydqh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GNGBF is a good fit for your portfolio.

Trading Information

Previous Close Price
$20.25
Day Range
$19.5619.80
52-Week Range
$16.7624.84
Bid/Ask
$19.82 / $20.32
Market Cap
$5.33 Bil
Volume/Avg
300 / 2,843

Key Statistics

Price/Earnings (Normalized)
25.88
Price/Sales
1.87
Dividend Yield (Trailing)
2.12%
Dividend Yield (Forward)
2.16%
Total Yield
2.12%

Company Profile

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
11,119

Competitors

Valuation

Metric
GNGBF
SYK
MDT
Price/Earnings (Normalized)
25.8832.9315.41
Price/Book Value
1.847.142.14
Price/Sales
1.876.533.44
Price/Cash Flow
12.6431.8115.17
Price/Earnings
GNGBF
SYK
MDT

Financial Strength

Metric
GNGBF
SYK
MDT
Quick Ratio
1.210.861.42
Current Ratio
1.931.582.29
Interest Coverage
12.0111.328.96
Quick Ratio
GNGBF
SYK
MDT

Profitability

Metric
GNGBF
SYK
MDT
Return on Assets (Normalized)
4.96%10.75%7.71%
Return on Equity (Normalized)
8.42%23.27%13.75%
Return on Invested Capital (Normalized)
7.50%14.37%9.80%
Return on Assets
GNGBF
SYK
MDT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesYnlrmby$205.9 Bil
SYK
Stryker CorpCxvsv$132.7 Bil
MDT
Medtronic PLCSyyx$110.7 Bil
BSX
Boston Scientific CorpJqxwmc$97.1 Bil
EW
Edwards Lifesciences CorpGvrjlkk$51.0 Bil
DXCM
DexCom IncQmsz$44.4 Bil
ZBH
Zimmer Biomet Holdings IncDcbsy$25.5 Bil
ALGN
Align Technology IncLxpqr$23.2 Bil
PHG
Koninklijke Philips NV ADRYzzmzz$18.2 Bil
SNN
Smith & Nephew PLC ADRHtjgqsr$11.5 Bil

Sponsor Center